ADRIANNA NOTTINGHAM: Open Payments
NPI 1386332021 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,877 in 69 payments from 24 companies in 2025. Trend: 2023 $134 · 2024 $3,476 · 2025 $1,877
Food & beverage: $1,877
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $351 |
| Janssen Biotech, Inc. | 7 | $332 |
| Lilly USA, LLC | 4 | $195 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $147 |
| Madrigal Pharmaceuticals | 3 | $93 |
| Ipsen Biopharmaceuticals, Inc | 3 | $79 |
| QOL Medical, LLC | 2 | $76 |
| Ardelyx, Inc. | 4 | $73 |
| Gilead Sciences, Inc. | 3 | $69 |
| GENZYME CORPORATION | 2 | $59 |
Products named: TREMFYA, RINVOQ, SKYRIZI, ENTYVIO, REZDIFFRA, IQIRVO, Sucraid, OMVOH.
Industry payments across VA — which companies pay providers there.
